Chikungunya Market Projected to Reach $1 Billion by 2030 Amidst Rising Global Health Concerns
The global market for chikungunya-related products and services is projected to reach $1 billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 9.1%. This expansion is driven by increasing investments in vaccine development, a greater emphasis on preventive healthcare strategies, and the expansion of vector control initiatives. The chikungunya virus (CHIKV), transmitted primarily by Aedes aegypti and Aedes albopictus mosquitoes, causes symptoms such as fever, severe joint pain, headaches, rash, and muscle aches. The rising prevalence of mosquito-borne diseases globally, influenced by factors like climate change, rapid urbanization, deforestation, and insufficient vector control, is a significant contributor to this market growth. The market is also seeing increased demand for rapid diagnostic tools and a boost in global funding for emerging infectious diseases. Key trends include advancements in vaccine candidates, wider adoption of antiviral therapies, and improved mosquito-borne disease moni...